MICHELLE HEAD: Open Payments
NPI 1568929826 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 35 payments from 10 companies in 2025. Trend: 2023 $2,087 · 2024 $1,865 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $195 |
| Teva Pharmaceuticals USA, Inc. | 5 | $157 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Lundbeck LLC | 2 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Corium, LLC | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, UZEDY, TRINTELLIX, SPRAVATO, FANAPT, Auvelity.
Industry payments across AR — which companies pay providers there.
